Download the Whitepaper

The Medpace Advantage for Nephrology & Renal Clinical Trials

Medpace has global experience conducting trials for a variety of kidney-related diseases from early through late phase. Our scientifically-driven approach to clinical development provides you the advantage of early and ongoing insight and guidance from therapeutic experts throughout trial design and execution.

You benefit from:

• In-house board-certified nephrologists with 40+ years of experience in clinical drug development, responsible for leading several drugs from early phase development through product launch
• Extensive global clinical trial experience in numerous nephrology indications
• Dedicated nephrology team with a thorough understanding of complex metabolic conditions that cause Chronic Kidney Disease (CKD), as well as the medical complications experienced by CKD and end-stage renal disease (ESRD) patients
• Well-established international relationships with experienced sites, networks, and KOLs specializing in nephrology
• A fully integrated solution with our in-house imaging core lab and global central lab to maximize efficiency